997 - The New Drug Igniting a Withdrawal Crisis
Episode Description
About this episode:
Medetomidine, a veterinary sedative similar to xylazine, is appearing more frequently in drug supplies in Maryland, Delaware, and Pennsylvania—and the withdrawal symptoms are debilitating. In this episode: Addiction medicine specialist Jordan Nahas-Vigon details the risks facing people who use drugs and why it's so difficult to quit.
Guests:
Dr. Jordan Nahas-Vigon is a primary care doctor with Johns Hopkins Medicine who specializes in addiction medicine.
Host:
Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department.
Show links and related content:
-
A Powerful New Drug Is Creating a 'Withdrawal Crisis' in Philadelphia—New York Times
-
Why the animal sedative behind a Baltimore mass overdose is so hard to quit—The Baltimore Banner
-
Sedative 'dex' is replacing 'tranq' in illegal drug supply and causing excruciating withdrawal—STAT
-
The Xylazine Crisis—Public Health On Call (May 2023)
Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
-
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

